Objective: To investigate the possible beneficial effects of a micronutrient supplementation to apparently healthy pregnant women on maternal biological status and new born anthropometric characteristics. Setting: Departments of Obstetric of the University Hospital of Grenoble (France) and Lyon (France), Laboratoire of Biology of Oxidative Stress, UFR de Pharmacie. Grenoble (France). Study design: Double-blind, randomized placebo-controlled intervention trial. Subjects: A total of 100 apparently healthy pregnant women were recruited at 1472 weeks of gestation to delivery. At the end, they were 65 women to follow out the study. Interventions: Daily consumption over gestation of a miconutrients supplement or placebo. Main outcome measures: Plasma micronutrient levels and oxidative stress parameters were measured in mothers at 14 and 38 weeks of gestation. New born's anthropometric characteristics were measured at delivery. Results: In the supplemented group, folic acid, vitamin C, E, B 2 , B 6 and b-carotene levels were higher than in the placebo group. Oxidative stress parameters were not different between the groups. Birth weights were increased by 10% and the number of low newborn weights (o2700g) decreased significantly when the mother received the supplementation. Maternal plasma Zn levels were positively correlated to the newborn heights. Conclusion: A regular intake of a micronutrient supplement at nutritional dose may be sufficient to improve micronutrient status of apparently healthy pregnant women and could prevent low birth weight of newborn. Sponsorship: The supplement and placebo were supplied and the study was partially funded by BOIRON Pharmaceutical Company.
Introduction
Alterations of mineral, trace element and vitamin status are well documented in pregnant women in relation with physiological, metabolic and hormonal changes (King, 2000) . The requirements for many micronutrients increase during pregnancy and the risk of maternal deficiencies must be considered since a marginal maternal status can adversely affect the obstetrical outcome. Micronutrient deficiencies contribute to impaired growth, health, and development (Ladipo, 2000) and the relation between maternal diet and the physical measurements of the new born has been described (Doyle et al, 1990) . In addition, intrauterine nutrition might influence the adult risk for chronic diseases (Godfrey & Parker, 2000) , suggesting that early nutrition has imprinting effects on later life. In developed countries, the incidence of acute micronutrient deficiencies is very low in young women, but several studies (Fidanza & Fidanza, 1986; Romon, 1997; Briefel et al, 2000; Giddens et al, 2000) showed that the percentage of apparently healthy pregnant women with marginal Mg, Ca, folic acid, vitamin C, Zn and Fe intakes was fairly high. Therefore, the potential benefits of a supplementation correcting the subdeficiencies in apparently healthy pregnant women should not be neglected. The beneficial effects of supplementation in pregnant women suffering from undernutrition and acute micronutrient deficiencies were widely reported in the developing countries (Osendarp et al, 2001 ). In contrast, few studies focused on the biological and clinical consequences for the mother and the new born of a multiple micronutrient supplementation during pregnancy in apparently healthy women.
The aim of this study was to assess the biological and clinical effects of a multivitamin multimineral supplement consumed at nutritional doses in apparently healthy pregnant women. Since, in pregnant women, it has been shown that the oxidative stress is increased (Cargnoni et al, 1994) and predictive of deleterious effects for the mother and the new born when it was not balanced by an optimal antioxidant micronutrient status, we focused on the correlation between some oxidative stress parameters and plasma micronutrient levels in pregnant women, and anthropometric measurements in the new born.
Methods

Subjects
A total of 100 apparently healthy women receiving prenatal care between 12 and 16 weeks of gestation in the Obstetric Departments of Grenoble and Lyon Hospitals in France were invited to participate in a double-blind, randomized, placebo-controlled trial. The study was approved by the Ethical Committee of Grenoble Hospital. Signed, informed consent was obtained from each woman at enrolment.
Treatment
Pregnant women were randomly assigned to a multiple micronutrient supplemented group (I, n ¼ 50) or a placebo group (II, n ¼ 50). They received the supplement or the placebo from 1472 weeks of gestation to delivery. The tablets were given out for 2 months, but with the recommendation to return the residual blisters every month. Volunteers were followed monthly for clinical examination and their compliance was evaluated at this time by the residual tablets, by the investigators. In total, 100 pregnant women were initially enrolled in the study and 65 completed the study (n ¼ 33 in the supplemented and n ¼ 32 in the placebo group). The compliance was equal or higher than 80%.
Supplementation
The subjects received a daily supplement containing vitamin C (60 mg), b-carotene (4.8 mg), vitamin E (10 mg), thiamin (1.4 mg), riboflavin (1.6 mg), niacin (15 mg), pantothenic acid (6 mg), folic acid (200 mg), cobalamin (1 mg), Zn (15 mg as citrate), Mg (87.5 mg as glycerophosphate), Ca (100 mg as carbonate) or a placebo. The supplement was iron free, regarding the oxidative potential effects of iron (Halliwell & Gutteridge, 1990) . The supplement and the placebo were provided by Boiron Pharmaceuticals (Ste Foy Les Lyon, France). The subjects, the hospital staff and the investigators were blinded to the coding scheme until analyses of the data were completed.
Clinical follow-up and sampling Clinical follow-up was carried out monthly. At birth, weight, height and clinical parameters were measured in newborns. Maternal blood samples were collected after overnight fasting, at the enrolment (1472 weeks) and at the last prenatal visit. Blood was immediately processed for plasma and red cell separation by centrifugation at 2000 rpm for 10 min in a refrigerated centrifuge. Plasma or red blood cells were frozen at À201C for vitamins B 2 , B 6 and B 12 , for folic acid, Zn, Cu, Ca and Mg, or at À801C for Cu-Zn SOD and vitamins A, E, b-carotene, SH and C ¼ O groups.
Micronutrient determinations
Plasma zinc and copper, and red blood cell copper concentrations were determined by flame atomic absorption spectrometry as previously described (Arnaud et al, 1985 (Arnaud et al, , 1986 . Red cell Cu-Zn SOD activity was measured after hemoglobin precipitation by monitoring the auto-oxidation of pyrogallol (Marklund & Marklund, 1974) . Plasma Mg, Ca and Fe and red blood cell Mg levels were measured using a Hitachi 917 (Roche Diagnostics). Thiamin, riboflavin and pyridoxal concentrations were evaluated, respectively, by erythrocyte transkelotase (ETK-AC), erythrocyte glutathione reductase (EGR-AC) and aspartate aminotransferase (EAST-AC) activation coefficients according to the previously published methods (Nichoalds et al, 1974; Bayoumi & Rosalki, 1976) . Enzyme activities were determined with and without added coenzymes (thiamin pyrophosphate, FAD and pyridoxal-5-phosphate). The activity ratios provided the erythrocyte activation coefficients. Vitamin B 12 and folic acid concentrations were carried out by radioimmuno assay kits (Dade-Behring, France). Plasma vitamin A, E and bcarotene levels were carried out by HPLC (Arnaud et al, 1991) and whole blood vitamin C concentrations according to Speek et al (1984) .
Oxidative stress parameters Parameter of lipid oxidation: plasma thiobarbituric reactive substances (TBARs) were determined as described (Richard et al, 1992) using the fluorimetric determination of malondialdehyde MDA-TBA (thiobarbituric acid) complex after extraction with n-butanol (Sobioda MDA fluorimetic kit, Grenoble, France).
Protein oxidation was evaluated by thiol and carbonyl groups: plasma thiol which is a parameter of non oxidation of SH groups was assayed in 100 ml of plasma, using 5,5 0 -dithiobid (2-nitrobenzoic acid) for derivating the thiol groups. Absorbance was measured at 412 nm (Faure & Lafond, 1995) . On the contrary, plasma carbonyl (C ¼ O), a marker of oxidation of protein, was quantified by reaction with 2,4-dinitrophenylhydrazine (Sigma Chemical Co., via Coger, Paris, France) (Faure & Lafond, 1995) .
Statistical analyses
Data were expressed as mean7s.d. P-values o 0.05 were considered as significant. Statistical analyses were carried out using unpaired Student's t or Mann-Whitney test. The Spearman correlation was used to examine the relation between selected variables. w 2 test was used to compare categorical variables between the groups. All analyses were performed using Statistica for Windows (StatSoft, Paris, France).
Results
Characteristics of the subjects Characteristics (Table 1 ) and micronutrient status (Tables 2  and 3 ) of the subjects at enrolment are presented. Before the supplementation, there were no significant differences between the two groups. All the median and mean values were in the normal range considering values for adult of the laboratory.
Biological effects of supplementation
In the supplemented group, we observed higher levels of vitamins C, E, B 6 (as EAST-AC), B 2 (as EGR-AC), folic acid and b-carotene than in the placebo group (Table 4) . Plasma B 1 status (as ETK-AC) and plasma B 12 concentrations were not different between the groups. Ca, Zn, Cu, Mg in plasma or red cells were not modified by the supplementation. The ratio of Zn/Cu and Cu-Zn SOD activity was similar in the two groups (Table 5 ). We did not find statistical differences between the groups regarding oxidative stress parameters (Table 6 ). Correlation between oxidative stress parameters and micronutrient status (Table 7) was positive for vitamin C concentration and Effects of micronutrients on pregnant women and newborn I Hininger et al SH groups, which are biological markers of protein protection against oxidative stress and negative for Zn levels and TBARS. Conversely, plasma C ¼ O groups, which are biological markers of amino acid and protein oxidation, were inversely correlated with Zn and vitamin C concentrations in plasma. 
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New born characteristics (Table 8) In the supplemented group, birth weights were increased by 10% but remained in the physiological range, whereas the number of infants with birth weights below 2700 g was significantly higher in placebo group (n ¼ 9 vs 2). There was a positive correlation between maternal plasma vitamin C levels and birth weights (r ¼ þ 0.33; P ¼ 0.02). The length of the new born was not significantly different between the groups but, in the supplemented group, it was significantly correlated to maternal zinc concentration in plasma (r ¼ þ 0.54; P ¼ 0.03) (Figure 1 ).
Discussion
In this study, apparently healthy pregnant women were randomly assigned in a placebo-controlled double-blind Effects of micronutrients on pregnant women and newborn I Hininger et al study to receive a daily combination of minerals, Mg, Ca, Zn, and vitamins (B, C, E, and b-carotenes), at nutritional doses, from 1472 weeks of gestation to delivery. As expected, the supplemental intake of vitamins was efficient to improve significantly the blood levels of vitamin E, C, b-carotenes, folic acid, B 2 and B 6 . In contrast, according to other studies, we confirmed that, in apparently healthy pregnant women, Zn supplemental intakes did not lead to an improved Zn plasma levels (Moser-Veillon & Reynolds, 1990) , nor an increase of antioxidant Cu-Zn SOD-activity (Tamura et al, 2001) in which Zn plays a stabilizing structural function. A decreased Zn bioavailability by competition between zinc and folic acid could be implicated (Milne et al, 1984; Ghisham et al, 1986) . However, the inhibitory effect of folates on zinc absorption is controversial, and recently Zavaleta et al (2000) observed an improved zinc status in Peruvian pregnant women receiving a zinc and folate supplement. Similar to Zn, Ca and Mg concentrations were not modified, which is not surprising regarding the homeostasis regulation and/or inappropriate indicators of status (Handwerker et al, 1996) . Furthermore, the Ca content of the supplement was low. Regarding a possible negative effect of Zn supplementation on Cu, or Fe (Porter et al, 1977; Lonnerdal, 1996) status or Ca supplementation on Mg status (Hallberg, 1998) , we did not observe modifications in the supplemented group compared to the placebo group (Table 5 ). Our data suggest that a supplementation of micronutrients at nutritional levels does not induce alterations of micronutrient plasma level consecutively to possible interactions and confirm the previous findings of other interventional studies (Reddy & Cook, 1997; Hallberg, 1998; Whittaker, 1998) .
It has been described that oxidative stress is increased during pregnancy (Takehara et al, 1990; Arikan et al, 2001) . When this increase is not balanced by an optimal antioxidant status, deleterious effects could be observed, such as teratogenic processes, diabetes (Eriksson & Borg, 1991; Bates et al, 1997) , pre-eclampsia (Hubel et al, 1989; Uotila et al, 1994) or intrauterine growth retardation (Schwarz et al, 1995) . In this study, we did not find statistical differences between the groups, regarding oxidative stress parameters probably in reason of the small sample size. However, we point out a positive correlation between antioxidant status and parameters of oxidation for all population confounding (Table 7) . In our study, mothers with a higher blood levels in Zn and vitamin C, which are essential antioxidant micronutrients, had less oxidation proteins and lipids monitored by SH group determination and TBARS. These potential beneficial effects, in apparently healthy pregnant women, could be of even greater effects in complicated pregnancies that have a high risk of uncontrolled oxidative stress (Brown et al, 1998) . Benefits of antioxidant supplementation on biological oxidative stress and clinical indices have been previously described in animal studies (Eriksson & Siman, 1996; Lira et al, 1998) and in randomized clinical trials (Poranen et al, 1996; Dreosti, 2001) . In parallel, we observed that, in the supplemented group, maternal zinc levels were positively correlated to the length of the new born. Zinc is essential for the growth, the beneficial effect of Zn on growth might be attributable to a direct role of zinc in protein synthesis and gene expression (Chappell et al, 1999; Cederberg et al, 2001) .
Finally, maternal supplementation resulted in a positive effect on infant birth weights, and significantly reduced the number of infants with birth weights below 2700 g which is associated with an increased risk of morbidity (McIntire et al, 1999) . Over 30 studies around the world have indicated that low birth weight babies who were not born prematurely have a higher incidence of hypertension later in life, and low birth weight, as well as thinness at birth, has also been correlated with glucose intolerance in childhood and noninsulin dependent diabetes in later life (UNICEF Report, 1998) . Other studies also reported a positive effect of supplementation using single micronutrient such as Zn (Jonnson et al, 1996; Shah & Sachdev, 2001; Tamura et al, 2001) , Mg (Makrides & Crowther, 2000) or folate (Iyengar & Rajalakshmi, 1975; Rolschau et al, 1981) . Recently, the role of vitamins E and C in preventing premature rupture of membrane, which could lead to an increased birth weight, was also hypothesized (Woods et al, 2001) . Since the gestational age was not different between the two groups, a possible influence of the maternal nutrient cannot be excluded.
Conclusions
This randomized double-blind study suggests that the use of combined micronutriment supplements, at nutritional doses, improved babies birth weight and maternal biological status. These preliminary results need to be confirmed in larger further studies, but suggest that optimal micronutrient nutrition should be encouraged, not only in women with poor nutritional status or in complicated pregnancies, but also in apparently healthy pregnant women, without any particular life style risk. Effects of micronutrients on pregnant women and newborn I Hininger et al
